gives everyone time to get in lol (i still have my shares from the last go around): Coupang Reschedules Third Quarter 2021 Results to November 12, 2021 https://finance.yahoo.com/news/coupang-reschedules-third-quarter-2021-010700414.html
$23.75 on the close. I wonder how many millions were lost on all those call options. Quite a few. Imagine that.
There's sectors, and then there's stocks. Elaborate. Why $77? Because it was at $90? That is the biggest trap there is. We have people that read this thread Stoney, that carries a certain degree of responsibility. Folks that are new to the market, they look at a stock and say "it was just at $90, I'm buying in at $70!" That's the biggest mistake in the world. Honestly, I would think you would know that. Is the Green Garden about short term momentum, or is it about wealth creation via stocks? It can certainly be both., but I think GBA has the responsibility of distinguishing between the two. For the folks that read this thread. Personally, I wouldn't touch this stock. Will Google or Amazon or a few others pull up the index and drag these things along? Maybe. But when the dust settles, water always seeks its level. I really think you should work harder on distinguishing a short term momentum play vs a long term wealth building play. It gives GBA more credibility. Which one is APPS?
Elaborate. Why $77? I photo extrapolate. I shut my eyes and envision the price the stk will rapidly move to. I did this yesterday when I brought up Xponential Fitness-- Xponential Fitness rallies after lifting full-year revenue guidance-- up 10% my friend. Q- Is the Green Garden about short term momentum, or is it about wealth creation via stocks? The GREEN GARDEN is about planting seeds of ideas that bloom. Time frame plays no roll. When I close my eyes I see APPS coming across a mythical ticker tape inmy mind.. this tape is always rolling and it says APPS $77.
So annoying i have to tell the wife she was right yet again- Xponential Fitness price target raised to $26 from $16 at Baird 06:59 XPOF Baird analyst Jonathan Komp raised the firm's price target on Xponential Fitness to $26 from $16 and keeps an Outperform rating on the shares. The analyst said he increased estimates to align with the company's raised 2021E guidance, and he views a higher valuation as justified by its solid execution which is increasing visibility to delivering the multi-year algorithm.
CohBar initiated with an Overweight at Cantor Fitzgerald 06:19 CWBR I was heavy into this stlk a few threads ago. It never really took off- --GBA SHORT REPORT-- ADDING EYE NAT VISION TO GRANNY'S SHORTS @$53-!
Aptose Biosciences price target raised to $14 from $9 at H.C. Wainwright 06:15 APTO $9-$14 would be a huge price raise for an $8 bio.... But this one is-$2.40
Coupang reports Q3 EPS (19c), consensus (17c) 06:04 CPNG Reports Q3 revenue $4.6B. Active customers grew at least 20% YoY for the 15th straight quarter. Beyond Air reports Q2 EPS (36c), consensus (28c) 16:14 XAIR Steve Lisi, CEO of Beyond Air commented, "This has been an exciting quarter for Beyond Air, as the team continues to deliver both operationally and strategically. On the strategic front, the launch of Beyond Cancer under the new leadership of CEO Selena Chaisson, M.D. is a special achievement. The separation of the UNO franchise to an independently managed affiliate was made possible through the support of investors in a $23.9M ongoing private financing. We believe that the spin-off will accelerate UNO's path to the clinic and create long-term value for shareholders. Beyond Cancer will leverage our NO expertise, IP portfolio, preclinical oncology team, regulatory progress, and initially use existing Company infrastructure. The separation enables Beyond Air to focus on its core business of advancing its LungFit platform for the treatment of respiratory diseases." Array Technologies reports Q3 adjusted EPS (7c), consensus (5c) 16:07 ARRY Reports Q3 revenue $192.07M, consensus $203.45M. "In the third quarter, we grew revenues 38%, generated over $315 million of new orders - the second highest level of quarterly bookings in our history - and ended the quarter with more than $1 billion in executed contracts and awarded orders, which is a new record for our company. Our results in the quarter demonstrate that the changes we made to our quoting and procurement processes have not impacted demand for our products or inhibited our ability to deliver for our customers. More importantly, we believe the third quarter represents the trough for our margins as it was the last quarter where the majority of our shipments were priced using our historical quoting and procurement processes. We expect that our gross margins should improve steadily over the next several quarters as new, higher margin orders constitute a larger and larger proportion of our shipments and legacy, lower price orders constitute a smaller and smaller proportion of our shipments." said Jim Fusaro, CEO of Array Technologies.
Digital Turbine could continue profitable growth, says Canaccord 15:00 APPS Canaccord analyst Austin Moldow reiterated a Buy rating and $100 price target on Digital Turbine after the company hosted an analyst day, where it discussed its comprehensive ad tech offering given recent acquisitions and the growth strategies to get the combined entities to the next level. Moldow believes there's a compelling case to be made for Digital Turbine to continue on its "impressive" history of execution and profitable growth. The analyst added that he believes the company has been able to add access to additional high quality inventory.